MyAverix Finance
ST · Healthcare
Karolinska Development AB ser. B (KDEV)
Biotechnology
Karolinska Development AB ser. B (KDEV) is listed on ST in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for KDEV
Karolinska Development AB ser. B (KDEV) — FAQ
What is KDEV's P/E ratio?
The price-to-earnings (P/E) ratio for Karolinska Development AB ser. B (KDEV) is 25.00 (data as of 2026-05-23).
Does Karolinska Development AB ser. B pay a dividend?
Dividend yield is not available in the current snapshot for Karolinska Development AB ser. B (KDEV). Check the MyAverix Finance app for the latest dividend data.
What sector is Karolinska Development AB ser. B in?
Karolinska Development AB ser. B (KDEV) is classified in the Healthcare sector (Biotechnology industry).
What exchange is KDEV listed on?
KDEV is listed on ST.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.